healthcare

How Aclaris Is On Track to Treat Baldness

Baldness and hair thinning is something that many men and women fear as they age, and understandably so. But Aclaris Therapeutics, Inc. (NASDAQ: ACRS) may have found an answer to ...
Read Full Story »

How Much Is Pfizer Overpaying For Array Bio?

Array BioPharma Inc. (NASDAQ: ARRY) shares shot up on Monday after the firm announced that it would be acquired by Pfizer Inc. (NYSE: PFE) in an all cash transaction. The ...
Read Full Story »

Investors Need Some Breathing Room From Savara’s Lung Treatment

Savara Inc. (NASDAQ: SVRA) shares were absolutely crushed on Thursday after the company released its late-stage results for its treatment of autoimmune pulmonary alveolar proteinosis (aPAP). Unfortunately, the study did ...
Read Full Story »

Short Sellers Raise Their Bets in Cannabis Stocks

Cannabis stocks had a huge showing on Wall Street last fall. In fact, most of the news flow surrounding these stocks had investors pouring money into them. Some of the ...
Read Full Story »

Big Biotechs Have Short Sellers on the Run

The short interest data are out for the most recent settlement date, May 31. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »

Big Pharma Sees a Rising Tide in Short Interest

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Meet the Newest Treatment for Autism Using Cannabidiol

With ever more states legalizing cannabis in the United States, it’s only a matter of time before it is legal across the country. After all, this drug does offer opportunities—outside ...
Read Full Story »

Is CymaBay Therapeutics’ Liver Disease Trial Sunk?

CymaBay Therapeutics Inc. (NASDAQ: CBAY) shares were nearly halved in Tuesday's premarket trading after the company provided an update from its midstage study of seladelpar for the treatment of nonalcoholic ...
Read Full Story »

Church of England Reverses Course, Okays Investments in Medical Marijuana

When Meghan Markle's nephew announced back in April 2018 that he was developing a new strain of cannabis to commemorate the royal wedding between his aunt and Britain's Prince Harry, ...
Read Full Story »

Why NovaBay Pharma Shares Absolutely Exploded

NovaBay Pharmaceuticals Inc. (NYSE: NBY) shares absolutely exploded on Monday after the company announced that its eye care treatment would be readily available on Amazon. Specifically, its Avenova Direct is ...
Read Full Story »

Why Tilray Shares Are Lighting Up

Tilray Inc. (NASDAQ: TLRY) shares jumped on Monday after the firm announced that it had signed a letter of intent with its largest stockholder, Privateer Holdings, for a transaction that ...
Read Full Story »

How ReWalk Is Capitalizing on Its Big Win

ReWalk Robotics Ltd. (NASDAQ: RWLK) shares took a step back on Monday after the firm announced that it would be pricing a registered direct offering for $5 million. This comes ...
Read Full Story »

The Pot Industry Will Soon Employ As Many People As the US Army

Cannabis, commonly known as marijuana, is legal for recreational use in 10 states and for medical use in 38. Growing, processing and selling cannabis has become a large enough business ...
Read Full Story »

5 ASCO Winners That Could Still More Than Double

The 55th annual meeting of the American Society of Clinical Oncology (ASCO) has just concluded, and there were some significant moves we saw as a result. Wedbush took a closer ...
Read Full Story »

Why Merrill Lynch Has High Hopes for Cronos

Cronos Group Inc. (NASDAQ: CRON) shares popped on Wednesday after Merrill Lynch released a very positive report. This is not something that happens every day, but the brokerage firm issued ...
Read Full Story »